Riboflavin (B2)
AAN Level B (probably effective) for migraine prevention at 400 mg/day, based on one small RCT.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- 400 mg/day, single oral dose
- Time to effect
- Benefit usually emerges between months 2 and 3
- Safety
- Has documented cautions
Evidence ratings summarise published research on Riboflavin (B2) in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Riboflavin (B2)
Interactions
Taking any medication?
Check Riboflavin (B2) against it.
Why
High-dose riboflavin has been studied for how often migraine attacks occur. Schoenen 1998 (Neurology) randomised 55 patients to 400 mg/day riboflavin vs placebo for 3 months: 59% of the riboflavin group versus 15% of placebo achieved ≥50% reduction in headache days. The trial is small and single. NICE advises that riboflavin at this dose may reduce migraine frequency and intensity for some people, and the 2012 AAN/AHS guideline on episodic migraine prevention rated it probably effective (Level B).
How it works
Precursor to FAD and FMN, cofactors for mitochondrial electron transport chain complexes I and II. The leading hypothesis is correction of subtle mitochondrial dysfunction in the migraine brain.
Expected onset · Benefit usually emerges between months 2 and 3; the Schoenen RCT measured outcomes at 3 months
How to take
Dosage
400 mg/day, single oral dose (the Schoenen 1998 protocol).
Timing
Once daily with food; consistent timing aids adherence
On the label
Look for 400 mg riboflavin (vitamin B2). Lower-dose B-complex products will not deliver the trial dose.
Studied in
Adults with episodic migraine discussing preventive options; the evidence rests on one small trial.
Safety
Evidence
Schoenen 1998 Neurology RCT (n=55, patients with migraine): 400 mg/day riboflavin for 3 months reduced attack frequency and headache days more than placebo; 59% versus 15% had at least a 50% reduction in headache days. NICE guideline CG150 (2012) advises that riboflavin at this dose may reduce migraine frequency and intensity for some people, and the AAN 2012 guideline rated it probably effective.
GRADE certainty: Low — rated by Healicus using the GRADE method
- Schoenen et al., Neurology 1998, RCT (n=55) of 400 mg riboflavin vs placebo for migraine prophylaxis (NNT 2.3)
- Holland et al., AAN/AHS evidence-based guideline update, Neurology 2012, riboflavin Level B for episodic migraine prevention
- NICE guideline (2012): Headaches in over 12s: diagnosis and management (CG150), rec. 1.3.23
Questions people ask
Does Riboflavin (B2) work?
Schoenen 1998 Neurology RCT (n=55, patients with migraine): 400 mg/day riboflavin for 3 months reduced attack frequency and headache days more than placebo; 59% versus 15% had at least a 50% reduction in headache days. NICE guideline CG150 (2012) advises that riboflavin at this dose may reduce migraine frequency and intensity for some people, and the AAN 2012 guideline rated it probably effective. Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is Riboflavin (B2) taken?
400 mg/day, single oral dose (the Schoenen 1998 protocol). Timing: Once daily with food; consistent timing aids adherence. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Turns urine bright yellow, an expected effect of riboflavin excretion. Rare mild diarrhoea or polyuria. Trials assessed benefit at 3 months. A new, changed or sudden severe headache needs medical assessment. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: Schoenen et al., Neurology 1998, RCT (n=55) of 400 mg riboflavin vs placebo for migraine prophylaxis (NNT 2.3); Holland et al., AAN/AHS evidence-based guideline update, Neurology 2012, riboflavin Level B for episodic migraine prevention; NICE guideline (2012): Headaches in over 12s: diagnosis and management (CG150), rec. 1.3.23.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.